Last updated on May 2019

A Study to Evaluate the Safety and Efficacy of CR845 in Chronic Kidney Disease Patients With Moderate-to-Severe Pruritus


Brief description of study

This is a multicenter, double-blind, randomized, placebo-controlled study to evaluate the safety and efficacy of 3 dose levels of oral CR845 compared to placebo in reducing the intensity of itch in chronic kidney disease (CKD) patients with moderate-to-severe pruritus. This study will consist of a Screening Period, a 7-day Run-in Period, a 12 week Treatment Period, and a Follow-up Visit (approximately 7 days after the last dose of study drug).

Detailed Study Description

This study will consist of a Screening Period, a 7-day Run-in Period, a 12 week Treatment Period, and a Follow-up Visit (approximately 7 to 10 days after the last dose of study drug). Informed consent will be obtained prior to performing any study-specific procedures. Screening will occur within 7 to 28 days prior to randomization to assess eligibility.

If patients continue to meet all inclusion and no exclusion criteria at the end of the 7-day Run-in Period, they will be randomized in a 1:1:1:1 ratio to receive orally once daily either placebo or CR845 tablets at doses of 0.25, 0.5 or 1 mg. Randomization will be stratified according to the patient's renal disease status: moderate CKD; severe CKD non-dialysis; severe CKD on dialysis (ie, 3 categories). A final safety Follow-up Visit will be conducted 7 to 10 days after the last dose of study drug.

Clinical Study Identifier: NCT03617536

Find a site near you

Start Over

Cara Therapeutics Study Site

Harrisburg, AR United States
  Connect »

Cara Therapeutics Study Site

Florence, AL United States
  Connect »

Cara Therapeutics Study Site

Prescott, AZ United States
  Connect »

Cara Therapeutics Study Site

Bakersfield, CA United States
  Connect »

Cara Therapeutics Study Site 2

Bakersfield, CA United States
  Connect »

Cara Therapeutics Study Site

Canyon Country, CA United States
  Connect »

Cara Therapeutics Study Site

Escondido, CA United States
  Connect »

Cara Therapeutics Study Site

Riverside, CA United States
  Connect »

Cara Therapeutics Study Site

Sacramento, CA United States
  Connect »

Cara Therapeutics Study Site

Whittier, CA United States
  Connect »

Cara Therapeutics Study Site

Washington, WA United States
  Connect »

Cara Therapeutics Study Site

Edgewater, FL United States
  Connect »

Cara Therapeutics Study Site

Hollywood, FL United States
  Connect »

Cara Therapeutics Study Site

Lake Worth, FL United States
  Connect »

Cara Therapeutics Study Site

Pembroke Pines, FL United States
  Connect »

Cara Therapeutics Study Site

Sandy Springs, GA United States
  Connect »

Cara Therapeutics Study Site

Crystal Lake, IL United States
  Connect »

Cara Therapeutics Study Site

Evanston, IL United States
  Connect »

Cara Therapeutics Study Site

Iowa City, IA United States
  Connect »

Cara Therapeutics Study Site

Metairie, LA United States
  Connect »

Cara Therapeutics Study Site

New Orleans, LA United States
  Connect »

Cara Therapeutics Study Site

Takoma Park, MD United States
  Connect »

Cara Therapeutics Study Site

Roseville, MI United States
  Connect »

Cara Therapeutics Study Site

Saint Clair, MI United States
  Connect »

Cara Therapeutics Study Site

Kansas City, MO United States
  Connect »

Cara Therapeutics Study Site

Brooklyn, NY United States
  Connect »

Cara Therapeutics Study Site

Rocky Mount, NC United States
  Connect »

Cara Therapeutics Study Site

Columbus, OH United States
  Connect »

Cara Therapeutics Study Site

Camp Hill, PA United States
  Connect »

Cara Therapeutics Study Site

Greenville, SC United States
  Connect »

Cara Therapeutics Study Site

Rapid City, SD United States
  Connect »

Cara Therapeutics Study Site

Corsicana, TX United States
  Connect »

Cara Therapeutics Study Site

Gonzales, TX United States
  Connect »

Cara Therapeutics Study Site

San Antonio, TX United States
  Connect »

Cara Therapeutics Study Site

Alexandria, VA United States
  Connect »

Cara Therapeutics Study Site

Providence, RI United States
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.